Intracameral recombinant tissue plasminogen activator (rtPA) as the primary treatment for secondary pupillary block

• Main Authors: AR, Siti Noor Atikah, Mohd Khialdin, Safinaz, Mustapha, Mushawiahti, MS, Muhammad Syamil, MZ, Ayesha
• Format: Article
• Published: Universiti Kebangsaan Malaysia. Faculty of Medicine 2022
• Online Access: http://psasir.upm.edu.my/id/eprint/101972/; https://www.researchgate.net/publication/361620632_Intracameral_Recombinant_Tissue_Plasminogen_Activator_rtPA_as_the_Primary_Treatment_for_Secondary_Pupillary_Block
• Institution: Universiti Putra Malaysia

Alteplase is a recombinant form of human tissue plasminogen activator (tPA) that converts plasminogen to plasmin essential for fibrinolysis. It is commonly used to treat embolic or thrombotic disorders such as ischemic stroke. Despite its rarity use in ophthalmology, we are reporting the effectivene...